- STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionRegenxbio said its experimental gene therapy for Duchenne muscular dystrophy succeeded in a trial, paving the way for a submission to the FDA.STAT · 2mo ago↗ source
- STAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chiefKyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the agency.STAT · 2mo ago↗ source
- STAT+: Treatment for alcohol addiction is undergoing a seismic shift. Many say it’s overdueThe surging popularity of alternatives to Alcoholics Anonymous represents a seismic shift in the alcohol treatment landscape. Many say it's overdue.STAT · 2mo ago